This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

Anti-Inflammatory Diet Linked to Reduced ... Adhering to an anti-inflammatory diet was associated with lower ... (17 Sep 2018)
Salsa dancers ‘less likely to get injured ... Salsa dancers are less likely to get injured while dancing than ... (17 Sep 2018)
Paracetamol use in infancy is linked to ...   Children who take paracetamol during their first two years ... (17 Sep 2018)
Diagnosing and treating resistant ... Resistant hypertension affects 12 to 15 percent of patients ... (11 Sep 2018)
Commonly used antidepressant drugs ... The difficulties that people have in discontinuing ... (13 Sep 2018)
Thursday, 08 September 2016 00:00

Patient Centricity

Written by
Rate this item
(0 votes)

W e, at Grünenthal, want to place the patient at the centre of our way of thinking and behavior.

Our daily work, as well as all strategic measures and decisions, are always guided by this vision. This means we set patient priorities and health as our first corporate goal to ensure we have a better understanding of the patient’s needs so that we can develop our business accordingly.

For us, to be patient-centric means: understanding and integrating the patients’ perspective and their unmet needs in our day-to-day activities and decision making. Identifying patients’ needs helps us to reflect how we, as a pharmaceutical company, can improve their situation with our daily work. This not only implies better treatment by e.g. providing better formulations, packaging and labeling, but also offering easy access to information on pain management.

In 2011 we decided to set up a patient ambassador program allowing us to stay in close contact with chronic pain patients. A patient ambassador at Grünenthal is either someone living with chronic pain or someone caring for a pain patient. In addition, these patient ambassadors share our objective: we all want to improve and change the lives of those suffering from chronic pain.

Through the patient ambassador program these patients or their carers have shared their stories with us and through them we have gained an in-depth insight into their lives and learned a lot about the challenges chronic pain patients are facing in their dayto-day life, their dreams and wishes.

The direct contact and integration of the ambassadors in our field of business also enable us to ask them for their open feedback and consultancy on various topics. In the past, several colleagues and departments took the opportunity to invite ambassadors to workshops or discussion rounds to ask for their input on e.g. formulations, packaging, how they rate different side-effects, and feedback on educational material for patients. Additionally they have access to our internal social network. This means that every employee has the possibility of starting discussions with the patient ambassadors and vice versa. This ensures that there is a continuous dialogue between employees and patient ambassadors which is one reason why the ambassadors are really integrated in the Grünenthal culture.

Sometimes, they also participate in external events organized in co-operation with health insurances, patient organizations, physicians and physiotherapists to raise awareness for a multimodal pain therapy approach among the general public. On these occasions the ambassadors share their experience and encourage other patient living with chronic pain not to give up and to work actively with their healthcare teams to find a treatment plan that works for them.

The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany.

Building on its unique position in pain treatment, its objective is to become the most patient-centric company in the field of pain and thus to be a leader in therapy innovation. Grünenthal is one of the last remaining five research-oriented pharmaceutical companies with headquarters in Germany which sustainably invests in research and development.

Additional Info

  • TheSynapse Magazines: 2014
Read 1706 times Last modified on Wednesday, 02 November 2016 21:25

TheSynapse Videos



  • WASP Course in Bahrain

    WASP Course, led by Prof Victor Grech and Prof Charles Savona Ventura, has recently organised a course in Bahrain. Co-hosted with Arabian Gulf University, the course, on how to write a scientific paper, focused on quantitative analysis methods and was targeted for medical doctors and allied health professionals.

    Written on April 24, 2018
  • Interactive Discussion on Valsartan



    The Malta Medicines Authority in collaboration with the Superintendence
    of Public Health and the Department of Pharmacy University of Malta
    would like to cordially invite you to an interactive scientific discussion:






    led by Professor Anthony Serracino Inglott


    Date: Wednesday 25 July 2018


    Time: 20:00
    Venue: Conference Room, Life Sciences Park, San Ġwann


    Refreshments will be served

    RSVP: | 23439202

    Written on July 21, 2018


Connect with other Medical Professionals on fb in a closed facebook group



Template Settings

Theme Colors

Cyan Red Green Oranges Teal


Wide Boxed Framed Rounded
Patterns for Layour: Boxed, Framed, Rounded
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…